Literature DB >> 22179828

MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.

B Zheng1, L Liang, S Huang, R Zha, L Liu, D Jia, Q Tian, Q Wang, C Wang, Z Long, Y Zhou, X Cao, C Du, Y Shi, X He.   

Abstract

Emerging evidence has shown that aberrantly expressed microRNAs (miRNAs) are highly associated with tumour development and progression. However, little is known about the potential role of miRNAs in gastric cancer (GC) metastasis. In this study, miR-409-3p was found to be downregulated frequently in human GCs, and its expression was significantly associated with tumor-node-metastasis (TNM) stage and lymph node metastasis. Enforced expression of miR-409 in GC cells significantly reduced their migration and invasion in vitro and their capacity to develop distal pulmonary metastases and peritoneal dissemination in vivo. Moreover, we found that miR-409 exerted its function predominantly through the mature miR-409-3p, but not miR-409-5p. Microarray and bioinformatics analysis identified the pro-metastatic gene radixin (RDX) as a potential miR-409-3p target. Further studies confirmed that miR-409-3p suppressed the expression of RDX by directly binding to its 3'-untranslated region. Silencing of RDX by small interfering RNAs phenocopied the effects of miR-409 overexpression, whereas restoration of RDX in miR-409-overexpressed GC cells reversed the suppressive effects of miR-409. Taken together, these results demonstrate that miR-409 suppresses GC cell invasion and metastasis by directly targeting RDX and that patients with downregulated miR-409-3p are prone to lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179828     DOI: 10.1038/onc.2011.581

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  53 in total

1.  Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.

Authors:  Danyi Mei; Haojun Song; Kai Wang; Yichao Lou; Weiliang Sun; Zhong Liu; Xiaoyun Ding; Junming Guo
Journal:  Med Oncol       Date:  2013-09-01       Impact factor: 3.064

Review 2.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

3.  Indirect Down-regulation of Tumor-suppressive let-7 Family MicroRNAs by LMO1 in Neuroblastoma.

Authors:  Norihisa Saeki; Akira Saito; Yuki Sugaya; Mitsuhiro Amemiya; Hiroki Sasaki
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

Review 4.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

Review 5.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

6.  LncRNA linc01116 prometes glioma cell migration and invasion by modulation of radixin targeted by miR-31.

Authors:  Nan Zhang; Kegang Shuai; Junjun Cheng; Wei Yang; Zhisheng Kan
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

7.  miR-409-3p suppresses the proliferation, invasion and migration of tongue squamous cell carcinoma via targeting RDX.

Authors:  Hujie Chen; Jing Dai
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

8.  MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.

Authors:  Ying Wang; Wenwen Lin; Jianghua Ju
Journal:  Cell Cycle       Date:  2020-04-15       Impact factor: 4.534

9.  Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.

Authors:  Han Christine Ngoc Nguyen; Wanling Xie; Ming Yang; Chen-Lin Hsieh; Sarah Drouin; Gwo-Shu Mary Lee; Philip W Kantoff
Journal:  Prostate       Date:  2012-08-10       Impact factor: 4.104

10.  The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.

Authors:  Xiaowen Hu; Jinyi Guo; Lan Zheng; Chunsheng Li; Tim M Zheng; Janos L Tanyi; Shun Liang; Chiara Benedetto; Marco Mitidieri; Dionyssios Katsaros; Xia Zhao; Youcheng Zhang; Qihong Huang; Lin Zhang
Journal:  Mol Cancer Res       Date:  2013-01-21       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.